Ahmad Mattour

机构：Henry Ford Health System, Henry Ford Hospital

发表论文 29 篇 · 总被引 162 次 · h-index 8

代表论文

• Real time patient‐reported outcome measures in patients with cancer: Early experience within an integrated health system (2023 · Cancer Medicine · 被引 36)
• 690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study (2023 · Annals of Oncology · 被引 29)
• Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors (2023 · Blood · 被引 18)
• The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification (2022 · Blood · 被引 14)
• Leptomeningeal Carcinomatosis (2022 · 被引 13)
• Preliminary Results of an Ongoing Phase 1 Dose Escalation Study of the Novel Anti-CD74 Antibody Drug Conjugate (ADC), STRO-001, in Patients with B-Cell Non-Hodgkin Lymphoma (2020 · Blood · 被引 10)